IRB Study Number 18-534
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Taussig Cancer Institute
Description
This study aims to develop a repository of blood samples from patients receiving CAR T-cell therapy at the Cleveland Clinic.
Inclusion Criteria
All patients who are being evaluated for IEC therapy at the Cleveland Clinic Blood and Marrow Transplant Program will be eligible to participate on this protocol. Patients will be recruited through the routine consenting process performed by the BMT physicians and nurse coordinators. Patients will be treated according to the BMT standard of care for IEC therapy or they may receive IEC under a clinical trial.
Exclusion Criteria
none
